Women’s Health market: Trends and Growth (3.84% CAGR) Segments Forecast 2016-2020

About Women's Health Market

Women’s health refers to the overall well-being experienced by women — this includes physical, mental, and social well-being. It deals with the diagnosis and treatment of various diseases and conditions that affect women such as HIV/AIDS, endometriosis, infertility, polycystic ovary syndrome, postmenopausal osteoporosis, and cancer (primarily ovarian and breast cancer). It also includes issues other than the biological conditions, like gender inequality (women are sometimes not able to afford medical treatments) or other socioeconomic issues.

Technavio’s analysts forecast the global women's health market to grow at a CAGR of 3.84% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global women's health market for 2016-2020. To calculate the market size, the report considers the revenue generated by the sales of drugs and devices for women's health issues.

The market is divided into the following segments based on geography:

• Americas

• APAC

• Europe

• MEA

Technavio's report, Global Women's Health Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Complete report details @ https://www.wiseguyreports.com/reports/417234/global-womens-health-market-2016-2020

Key vendors

• Allergan

• Bayer HealthCare

• Merck

• Pfizer

• Teva Pharmaceuticals

Other prominent vendors

• Agile Therapeutics

• Amgen

• Apothecus Pharmaceutical

• AstraZeneca

• Blairex Laboratories

• Bristol-Myers Squibb

• EffRx

• Ferring International Center

• GlaxoSmithKline

• HLL Lifecare

• Janssen Pharmaceutical

• Lipocine

• Ligand Pharmaceuticals

• Lupin Pharmaceuticals

• Mayer Laboratories

• Medicines 360

• Neurocrine Biosciences

• Novartis

• Novo Nordisk

• Pantarhei Bioscience

• Sanofi

Market driver

• Rise in number of older women worldwide

• For a full, detailed list, view our report

Market challenge

• High cost and inaccessibility of health services

• For a full, detailed list, view our report

Market trend

• Rise in STIs

• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/417234/global-womens-health-market-2016-2020

Table of content

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview

• Top-vendor offerings

PART 03: Market research methodology

• Research methodology

• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Market landscape

• Market overview

• Market size and forecast

• Five forces analysis

PART 06: Market segmentation by application

• Market overview

• Global postmenopausal osteoporosis market

• Global contraceptives market

• Global infertility market

• Global menopause market

• Global endometriosis market

• Global polycystic ovary syndrome market

PART 07: Geographical segmentation

• Market overview

• Women's health market in Americas

• Women's health market in Europe

• Women's health market in APAC

• Women's health market in MEA

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

• Competitive scenario

PART 14: Key vendor analysis

• Allergan

• Bayer HealthCare

• Merck

• Pfizer

• Teva Pharmaceuticals

• Other prominent vendors

PART 15: Appendix

• List of abbreviations

PART 16: Explore Technavio

 Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=417234

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)